ProShare Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Sell |
14,910
-127
| -0.8% | -$2.22K | ﹤0.01% | 1547 |
|
|
2025
Q1 | $189K | Sell |
15,037
-3,426
| -19% | -$43.1K | ﹤0.01% | 1707 |
|
|
2024
Q4 | $195K | Buy |
18,463
+3,436
| +23% | +$36.3K | ﹤0.01% | 1895 |
|
|
2024
Q3 | $218K | Buy |
+15,027
| New | +$218K | ﹤0.01% | 1675 |
|
|
2024
Q2 | – | Sell |
-11,139
| Closed | -$114K | – | 1993 |
|
|
2024
Q1 | $114K | Buy |
11,139
+942
| +9% | +$9.63K | ﹤0.01% | 1798 |
|
|
2023
Q4 | $55.9K | Buy |
+10,197
| New | +$55.9K | ﹤0.01% | 1847 |
|